Stock analysts at Piper Jaffray Companies began coverage on shares of Core Laboratories (NYSE:CLB) in a report released on Tuesday, MarketBeat Ratings reports. The brokerage set a “neutral” rating and a $96.00 price target on the oil and gas company’s stock. Piper Jaffray Companies’ price objective indicates a potential downside of 11.06% from the stock’s previous close.

Other equities research analysts also recently issued reports about the company. TheStreet upgraded Core Laboratories from a “c” rating to a “b-” rating in a report on Thursday, February 1st. ABN Amro downgraded Core Laboratories from a “buy” rating to a “hold” rating in a report on Tuesday, January 9th. Royal Bank of Canada set a $125.00 target price on Core Laboratories and gave the company a “buy” rating in a report on Tuesday, January 30th. Deutsche Bank downgraded Core Laboratories from a “buy” rating to a “hold” rating and dropped their target price for the company from $116.30 to $109.00 in a report on Thursday, January 11th. Finally, ValuEngine downgraded Core Laboratories from a “hold” rating to a “sell” rating in a report on Thursday, March 1st. Two research analysts have rated the stock with a sell rating, nine have assigned a hold rating and four have issued a buy rating to the stock. The company currently has an average rating of “Hold” and a consensus target price of $111.60.

How to Become a New Pot Stock Millionaire

Core Laboratories (CLB) opened at $107.94 on Tuesday. The company has a market capitalization of $4,770.00, a PE ratio of 56.51 and a beta of 1.47. The company has a quick ratio of 1.66, a current ratio of 1.98 and a debt-to-equity ratio of 1.53. Core Laboratories has a twelve month low of $86.55 and a twelve month high of $121.39.

Core Laboratories (NYSE:CLB) last released its quarterly earnings data on Wednesday, January 31st. The oil and gas company reported $0.58 EPS for the quarter, hitting analysts’ consensus estimates of $0.58. The company had revenue of $172.00 million for the quarter, compared to the consensus estimate of $171.92 million. Core Laboratories had a return on equity of 58.25% and a net margin of 12.60%. The company’s quarterly revenue was up 15.1% compared to the same quarter last year. During the same period last year, the business posted $0.41 EPS. equities research analysts anticipate that Core Laboratories will post 2.66 earnings per share for the current year.

A number of hedge funds have recently bought and sold shares of the business. WCM Investment Management CA increased its holdings in Core Laboratories by 5.5% during the 4th quarter. WCM Investment Management CA now owns 4,793,731 shares of the oil and gas company’s stock worth $525,153,000 after purchasing an additional 250,830 shares during the last quarter. Kayne Anderson Rudnick Investment Management LLC increased its holdings in Core Laboratories by 19.0% during the 3rd quarter. Kayne Anderson Rudnick Investment Management LLC now owns 2,025,357 shares of the oil and gas company’s stock worth $199,904,000 after purchasing an additional 323,357 shares during the last quarter. Earnest Partners LLC increased its holdings in Core Laboratories by 6.3% during the 3rd quarter. Earnest Partners LLC now owns 1,951,719 shares of the oil and gas company’s stock worth $192,635,000 after purchasing an additional 115,982 shares during the last quarter. JPMorgan Chase & Co. increased its holdings in Core Laboratories by 14.9% during the 3rd quarter. JPMorgan Chase & Co. now owns 935,695 shares of the oil and gas company’s stock worth $91,904,000 after purchasing an additional 121,553 shares during the last quarter. Finally, Russell Investments Group Ltd. increased its holdings in Core Laboratories by 10.7% during the 3rd quarter. Russell Investments Group Ltd. now owns 895,405 shares of the oil and gas company’s stock worth $88,373,000 after purchasing an additional 86,407 shares during the last quarter.

COPYRIGHT VIOLATION WARNING: This article was reported by Daily Political and is the sole property of of Daily Political. If you are viewing this article on another domain, it was copied illegally and reposted in violation of international copyright and trademark law. The correct version of this article can be accessed at https://www.dailypolitical.com/2018/03/14/core-laboratories-clb-coverage-initiated-by-analysts-at-piper-jaffray-companies.html.

Core Laboratories Company Profile

Core Laboratories N.V. provides reservoir description, production enhancement and reservoir management services to the oil and gas industry. The Company operates through three segments: Reservoir Description, Production Enhancement and Reservoir Management. The Reservoir Description segment encompasses the characterization of petroleum reservoir rock, fluid and gas samples.

Analyst Recommendations for Core Laboratories (NYSE:CLB)

Receive News & Ratings for Core Laboratories Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Core Laboratories and related companies with MarketBeat.com's FREE daily email newsletter.